Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.28 USD | +15.54% | +25.27% | +2.72% |
Financials (USD)
Sales 2024 * | 1.06M | Sales 2025 * | 170K | Capitalization | 143M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -61M | EV / Sales 2024 * | 26.9 x |
Net cash position 2024 * | 114M | Net cash position 2025 * | 60.6M | EV / Sales 2025 * | 484 x |
P/E ratio 2024 * |
-3.31
x | P/E ratio 2025 * |
-2.7
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.81% |
Latest transcript on Vistagen Therapeutics, Inc.
1 day | +15.54% | ||
1 week | +25.27% | ||
Current month | +3.33% | ||
1 month | +1.34% | ||
3 months | +0.76% | ||
6 months | +1.93% | ||
Current year | +2.72% |
Managers | Title | Age | Since |
---|---|---|---|
Shawn Singh
CEO | Chief Executive Officer | 61 | 99-12-31 |
Cynthia Anderson
DFI | Director of Finance/CFO | 55 | 23-08-20 |
Joshua Prince
COO | Chief Operating Officer | 54 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Saxe
CHM | Chairman | 88 | 00-05-31 |
Jerry Gin
BRD | Director/Board Member | 81 | 16-02-29 |
Shawn Singh
CEO | Chief Executive Officer | 61 | 99-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 17 M€ | +5.93% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 5.28 | +15.54% | 1,235,632 |
24-03-27 | 4.57 | +5.06% | 324,181 |
24-03-26 | 4.35 | +1.64% | 173,613 |
24-03-25 | 4.28 | +2.64% | 224,707 |
24-03-22 | 4.17 | -1.07% | 132,516 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.72% | 143M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |